Follow
Sally Meikle
Title
Cited by
Cited by
Year
Psilocybin-assisted therapy for depression: How do we advance the field?
SE Meikle, P Liknaitzky, SL Rossell, M Ross, N Strauss, N Thomas, ...
Australian & New Zealand Journal of Psychiatry 54 (3), 225-231, 2020
232020
Individual differences in distress, impulsivity, and coping motives for use as predictors of problematic ecstasy use
S Meikle, O Carter, G Bedi
Addictive Behaviors 108, 106397, 2020
82020
Psychedelic-assisted psychotherapy, patient vulnerability and abuses of power
S Meikle, O Carter, G Bedi
Australian & New Zealand Journal of Psychiatry 58 (2), 104-106, 2024
12024
Side-effects of MDMA-assisted Psychotherapy: A Systematic Review and Meta-analysis
J Colcott, AA Guerin, O Carter, S Meikle, G Bedi
Neuropsychopharmacology, 1-19, 2024
2024
Why didn’t the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?
SL Rossell, SE Meikle, ML Williams, DJ Castle
Australian & New Zealand Journal of Psychiatry 57 (7), 935-936, 2023
2023
PSILOCYBIN-ASSISTED THERAPY FOR MENTAL HEALTH: HOW DO WE ADVANCE THE FIELD?
S Meikle, P Liknaitzky, S Rossell, M Ross, N Strauss, N Thomas, G Murray, ...
Deakin University, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–6